Amendment 1 to License AgreementLicense Agreement • December 10th, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • Florida
THIS AMENDMENT (“Amendment”) to the License Agreement is hereby made and entered into on December 7, 2020, by and between the University of Miami, a Florida not-for-profit corporation having an address of 1951 NW 7th Ave., Suite. 300, Miami, FL 33136 (“Licensor”) and Heat Biologics Inc., having business offices at 627 Davis Drive, Suite 400, Morrisville, NC 27560 (“Licensee”).
Amendment 1 to License AgreementLicense Agreement • December 10th, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • Florida
THIS AMENDMENT (“Amendment”) to the License Agreement is hereby made and entered into on December 7, 2020, by and between the University of Miami, a Florida not-for-profit corporation having an address of 1951 NW 7th Ave., Suite. 300, Miami, FL 33136 (“Licensor”) and Pelican Therapeutics, Inc. (a subsidiary of Heat Biologics, Inc., and formerly known as Heat Biologics II, Inc.) a Delaware corporation having an address of 8122 Datapoint Drive, Suite 445, San Antonio, TX 78229 (“Licensee”).
Amendment 3 to License AgreementLicense Agreement • December 10th, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • Florida
THIS AMENDMENT Number 3 (“Amendment”) to the License Agreement is hereby made and entered into on December 7, 2020, by and between the University of Miami, a Florida not-for-profit corporation having an address of 1951 NW 7th Ave., Suite. 300, Miami, FL 33136 (“Licensor”) and Heat Biologics Inc., having business offices at 627 Davis Drive, Suite 400, Morrisville, NC 27560 (“Licensee”).
